𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is immunotherapy a reasonable approach for the treatment of esophageal cancer?

✍ Scribed by J. Friedl; S. Riss; A. Stift

Publisher
Blackwell Publishing
Year
2007
Tongue
German
Weight
392 KB
Volume
39
Category
Article
ISSN
0001-544X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Personalized immunotherapy for the treat
Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach
✍ Julie M Vose πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 174 KB

The efficacy of immunotherapeutic strategies for the treatment of lymphoid malignancies has been demonstrated in recent years. In patients with B-cell lymphomas, particularly indolent lymphoma, the use of passive immunotherapy, such as the anti-CD20 monoclonal antibody rituximab, has made an impress

Neoadjuvant strategies for the treatment
Neoadjuvant strategies for the treatment of locally advanced esophageal cancer
✍ John R. Hyngstrom; Mitchell C. Posner πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Abstract Patients with locally advanced esophageal carcinoma have consistently poor survival following surgery with associated high systemic and local‐regional failure rates. Neoadjuvant therapeutic strategies have been employed in an attempt to improve outcome with variable success. Randomized